• Genes and health
• Conditions we cover
• Breast Cancer
• Complete scan
• Cancer scan
• Cardio scan
• Advanced features

The deCODEme breast cancer test focuses on the common forms of breast cancer.

At deCODEme, your genetic test is based on the best science available

Testing yourself for breast cancer risk is a personal and private decision

Making the choice to test yourself for the common genetic variants associated with breast cancer is a personal and private decision. At deCODEme, we respect your decision and value your trust, and want you to know, that our scientists select only the best, most reliable, science on which to base your results. Needless to say, the security and privacy of your results is one of our biggest priorities.

The deCODEme genetic test for breast cancer risk is based on solid science

Quality is of utmost importance when you select a provider for genetic testing and we are confident that deCODEme is exceptional when compared to rival products. Our customers benefit directly from the expertise of scientists at deCODE Genetics, a company with an unparalleled track record in gene discovery for common diseases.

We strive to make our genetic scans as comprehensive and reliable as possible. Thus, for any given disease, we measure all the most important genetic risk variants (SNPs) that are supported by solid scientific evidence

Here´s how it works!

deCODEme calculates your genetic risk of breast cancer

The deCODEme breast cancer test focuses primarily on identifying the common genetic risk variants associated with breast cancer, accounting for about 90% of breast cancer cases. The deCODEme Complete Scan and the deCODEme Cancer Scan identify eleven common genetic variants and provide interpretation of their associated risk for developing breast cancer in individuals of European descent (see scientific details).

For individuals of East-Asian descent the deCODEme Genetic Scans calculate genetic risk associated with the five variants validated in this population. At the present time no risk estimation data are available for people of other ethnicities for the variants mentioned.

The deCODEme genetic test for breast cancer is a risk test

It is important to understand that the deCODEme genetic test for breast cancer is a risk test. As such, it tells you how your personal genetics compares to the genetics of large numbers of people in studies of the genetics of breast cancer. The deCODEme genetic scan is not a diagnostic test, in that it will not tell you whether you already have breast cancer, nor can it tell you whether you will, or will not, develop breast cancer in the future. What the deCODEme genetic test can do, is help you determine your life-time risk of developing breast cancer, compared to the average risk within the population to which you belong (for example compared to other males, females, age groups, ethnic groups).

Test your knowledge of breast cancer

You can test your knowledge of breast cancer by visiting the National Cancer Institute´s interactive Web site. Take their test and learn more about your breast cancer risk and how to lower it.

This content was last reviewed on February 09, 2010.

The conditions we cover: ABO Blood Types, Abdominal Aortic Aneurysm, Age Related Macular Degeneration, Alcohol Flush Reaction, Alzheimer’s Disease, Asthma, Atrial Fibrillation, Basal Cell Carcinoma, Bitter Taste Perception, Bladder Cancer, Brain Aneurysm, Brain Cancer-Glioma, Breast Cancer, Celiac Disease, Chronic Kidney Disease, Chronic Lymphocytic Leukemia, Chronic Obstructive Pulmonary Disease, Colorectal Cancer, Crohn’s Disease, Essential Tremor, Exfoliation Glaucoma, Eye Color, Gallstones, Gout, Heart Attack, Hemochromatosis, Hypertension, Kidney Stones, Lactose Intolerance, Lung Cancer, Male Pattern Baldness, Multiple Sclerosis, Nicotine Dependence, Obesity, Ovarian Cancer, Pancreatic Cancer, Peripheral Arterial Disease, Prostate Cancer, Psoriasis, Restless Legs Syndrome, Rheumatoid Arthritis, Statin Induced Myopathy, Systemic Lupus Erythematosus, Testicular Cancer, Thyroid Cancer, Type 1 Diabetes, Type 2 Diabetes, Ulcerative Colitis, Venous Thromboembolism, Warfarin Metabolism.